VA Connecticut Healthcare System
West Haven, Connecticut, 06516, United States
NCT Number: NCT01579422
The primary aim of this proposal is to develop, refine, manualize and assess the feasibility and preliminary efficacy of a brief, narrowly-focused social cognitive intervention for individuals with psychosis. The intervention will focus on helping individuals interpret social situations, specifically the intentions and feelings of others.
Study methods include preliminary treatment and manual development based on series of uncontrolled cases, manual refinement, and a small feasibility/efficacy trial of the newly developed intervention.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Phase 1
West Haven, Connecticut, 06516, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
social cognitive training, 8-10 sessions
Time frame: change from baseline to approximately 6 weeks
AIHQ Eyes Task Hinting Task IPSAQ
Yale University
Other
Social Cognitive Training for Psychosis: Phase I Treatment Development
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05808244
Mental Disorders, Psychosis
Kowloon, Hong Kong
View Trial DetailsNCT04004416
Bipolar Disorder, Bipolar and Related Disorders
Ann Arbor, Michigan, United States
View Trial DetailsNCT05766007
Antipsychotic Agents, Behavior
Makurdi, Benue State, Nigeria
View Trial DetailsNCT03919760
Affective Disorders, Psychotic, Behavior
Greater Sudbury, Ontario, Canada
View Trial Details